AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voginit-GM2/0.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Nitro Organics

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voginit-GM2/0.3 Tablet SR

Diabex-Duo 2/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabex-Duo 2/0.3mg Extended-Release Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including renal impairment, vision loss, neuropathy, and limb amputation. This medication is a component of a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are critical to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, lightheadedness, headache, and tremors. Prompt recognition and treatment are essential; maintaining regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks, fruit juice) are recommended preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Voginit-GM2/0.3 Tablet SR

There is no text provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Voginit-GM2/0.3 Tablet SR

Managing type 2 diabetes

Major Benefits of Voginit-GM2/0.3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voginit-GM2/0.3 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Voginit-GM2/0.3 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voginit-GM2/0.3 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Voginit-GM2/0.3 Tablet SR on an empty stomach.

How Voginit-GM2/0.3 Tablet SR works:

Voginit-GM2/0.3 extended-release tablets contain a triple-drug regimen for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voginit-GM2/0.3 Tablet SR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voginit-GM2/0.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Voginit-GM2/0.3 Tablet likely poses a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voginit-GM2/0.3 Tablet SR, as its use may be unsafe. Medical advice is necessary before taking this medication. The use of Voginit-GM2/0.3 Tablet SR is particularly discouraged for individuals with severely impaired kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Voginit-GM2/0.3 SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, a low initial dose is typically prescribed; however, this medication is unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Voginit-GM2/0.3 Tablet SR :

Should you forget a Voginit-GM2/0.3 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voginit-GM2/0.3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Voginit-GM2/0.3 Tablet SR

Voginit-GM2/0.3 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Voginit-GM2/0.3 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infection.
Voginit-GM2/0.3 Tablet SR is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Voginit-GM2/0.3 Tablet SR with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voginit-GM2/0.3 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Voginit-GM2/0.3 Tablet SR
119
MRP 145
17% off